Showing results (1-10 of 292) with videos related to
Sort By:
Pageof 30
Archives of Internal Medicine|April 1, 1998
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?S J Khoury, H L WeinerJournal of Neuroimmunology|August 30, 2001
Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MSK Makhlouf, H L Weiner, S J KhouryThe Journal of Experimental Medicine|November 1, 1992
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brainS J Khoury, W W Hancock, H L WeinerCellular Immunology|December 1, 1990
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharideS J Khoury, O Lider, A al-Sabbagh, et al.The Journal of Clinical Investigation|June 1, 1995
Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosisK E Balashov, S J Khoury, D A Hafler, et al.Journal of Neuroimmunology|June 30, 2001
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosisK Makhlouf, M Comabella, J Imitola, et al.Cellular Immunology|April 15, 1990
Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cellsL M Santos, O Lider, J Audette, et al.Neurology|July 26, 2000
Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MSK E Balashov, M Comabella, T Ohashi, et al.The Journal of Clinical Investigation|August 26, 1998
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapyM Comabella, K Balashov, S Issazadeh, et al.Annals of the New York Academy of Sciences|February 13, 1996
Mechanisms of oral tolerance by MHC peptidesM H Sayegh, S J Khoury, W W Hancock, et al.Pageof 30